SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Sep-24 5:47 PM View: | Relmada Therapeutics, Inc. (RLMD) | 11-Sep-24 | Purchase | 51,407 | $2.99 | $153,707.00 | 15% 332.62K to 384.02K | |
11-Sep-24 5:47 PM View: | Relmada Therapeutics, Inc. (RLMD) | 10-Sep-24 | Purchase | 33,014 | $2.75 | $90,788.50 | 11% 299.6K to 332.62K | |
11-Sep-24 5:47 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Sep-24 | Private Purchase | 55,579 | $2.71 | $150,619.00 | 23% 244.02K to 299.6K | |
31-Jan-24 6:29 PM View: | Relmada Therapeutics, Inc. (RLMD) | 31-Jan-24 | Purchase | 27,460 | $4.00 | $109,752.00 | 13% 216.56K to 244.02K | |
31-Jan-24 6:29 PM View: | Relmada Therapeutics, Inc. (RLMD) | 30-Jan-24 | Purchase | 40,999 | $3.90 | $159,949.00 | 23% 175.56K to 216.56K | |
31-Jan-24 6:29 PM View: | Relmada Therapeutics, Inc. (RLMD) | 29-Jan-24 | Private Purchase | 31,541 | $3.71 | $117,036.00 | 22% 144.02K to 175.56K | |
12-Dec-22 8:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 08-Dec-22 | Private Purchase | 55,250 | $2.10 | $115,804.00 | 62% 88.77K to 144.02K | |
05-Jul-22 4:30 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Jul-22 | Option Exercise | 13,755 | $16.00 | $220,080.00 | 15% 88.77K to 102.53K | |
05-Jul-22 4:30 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Jul-22 | Option Sale | 13,755 | $18.41 | $253,276.00 | (13%) 102.53K to 88.77K | |
05-Jul-22 4:30 PM View: | Relmada Therapeutics, Inc. (RLMD) | 30-Jun-22 | Option Exercise | 16,012 | $16.00 | $256,192.00 | 18% 88.77K to 104.79K | |
05-Jul-22 4:30 PM View: | Relmada Therapeutics, Inc. (RLMD) | 30-Jun-22 | Option Sale | 16,012 | $19.13 | $306,301.00 | (15%) 104.79K to 88.77K | |
11-Mar-21 5:51 PM View: | Relmada Therapeutics, Inc. (RLMD) | 10-Mar-21 | Market Option Sale | 2,983 | $35.09 | $104,676.00 | (3%) 91.76K to 88.77K | |
11-Mar-21 5:51 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 11% 88.77K to 98.77K | |
11-Mar-21 5:51 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Market Option Sale | 7,017 | $35.65 | $250,169.00 | (7%) 98.77K to 91.76K | |
26-Feb-21 4:50 PM View: | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 11% 88.77K to 98.77K | |
26-Feb-21 4:50 PM View: | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Market Option Sale | 10,000 | $34.24 | $342,392.00 | (10%) 98.77K to 88.77K | |
16-Feb-21 5:10 PM View: | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Option Exercise | 1,446 | $3.24 | $4,685.04 | 2% 88.77K to 90.22K | |
16-Feb-21 5:10 PM View: | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Market Option Sale | 1,446 | $35.43 | $51,238.40 | (2%) 90.22K to 88.77K | |
10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 10-Feb-21 | Market Option Sale | 1,930 | $35.28 | $68,097.20 | (2%) 90.7K to 88.77K | |
10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Feb-21 | Market Option Sale | 5,963 | $35.21 | $209,939.00 | (6%) 96.67K to 90.7K | |
10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 08-Feb-21 | Option Exercise | 11,206 | $3.24 | $36,307.40 | 13% 88.77K to 99.98K | |
10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 08-Feb-21 | Market Option Sale | 3,313 | $35.03 | $116,049.00 | (3%) 99.98K to 96.67K | |
04-Feb-21 5:40 PM View: | Relmada Therapeutics, Inc. (RLMD) | 03-Feb-21 | Market Option Sale | 100 | $35.00 | $3,500.00 | (< 1%) 88.97K to 88.87K | |
04-Feb-21 5:40 PM View: | Relmada Therapeutics, Inc. (RLMD) | 02-Feb-21 | Option Exercise | 3,278 | $3.24 | $10,620.70 | 4% 88.77K to 92.05K | |
04-Feb-21 5:42 PM View: | Relmada Therapeutics, Inc. (RLMD) | 02-Feb-21 | Option Exercise | 13,281 | $3.24 | $43,030.40 | 18% 75.49K to 88.77K | |
04-Feb-21 5:40 PM View: | Relmada Therapeutics, Inc. (RLMD) | 02-Feb-21 | Market Option Sale | 3,178 | $35.08 | $111,470.00 | (3%) 92.05K to 88.87K | |
29-Jan-21 5:22 PM View: | Relmada Therapeutics, Inc. (RLMD) | 27-Jan-21 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 13% 75.49K to 85.49K | |
29-Jan-21 5:22 PM View: | Relmada Therapeutics, Inc. (RLMD) | 27-Jan-21 | Market Option Sale | 10,000 | $32.39 | $323,914.00 | (12%) 85.49K to 75.49K | |
26-Jan-21 7:29 PM View: | Relmada Therapeutics, Inc. (RLMD) | 26-Jan-21 | Market Option Sale | 600 | $35.15 | $21,090.00 | (< 1%) 76.09K to 75.49K | |
26-Jan-21 7:29 PM View: | Relmada Therapeutics, Inc. (RLMD) | 25-Jan-21 | Market Option Sale | 1,300 | $35.29 | $45,877.00 | (2%) 77.39K to 76.09K | |
26-Jan-21 7:29 PM View: | Relmada Therapeutics, Inc. (RLMD) | 22-Jan-21 | Option Exercise | 4,070 | $3.24 | $13,186.80 | 5% 75.49K to 79.56K | |
26-Jan-21 7:29 PM View: | Relmada Therapeutics, Inc. (RLMD) | 22-Jan-21 | Market Option Sale | 2,170 | $35.58 | $77,212.90 | (3%) 79.56K to 77.39K | |
19-Aug-20 4:15 PM View: | Relmada Therapeutics, Inc. (RLMD) | 18-Aug-20 | Payment of Exercise | 4,151 | $39.03 | $162,014.00 | (5%) 79.64K to 75.49K | 18% |
19-Aug-20 4:15 PM View: | Relmada Therapeutics, Inc. (RLMD) | 18-Aug-20 | Option Exercise | 50,008 | $3.24 | $162,026.00 | 169% 29.64K to 79.64K | (1%) |
18-Apr-16 5:24 PM View: | Actinium Pharmaceuticals, I... (ATNM) | 15-Apr-16 | Purchase | 1,000 | $2.02 | $2,020.00 | 50% 2.0K to 3.0K | |
18-Apr-16 5:24 PM View: | Actinium Pharmaceuticals, I... (ATNM) | 14-Apr-16 | Purchase | 2,000 | $2.02 | $4,040.00 | 100% 0 to 2.0K | |
17-Dec-15 9:36 AM View: | Relmada Therapeutics, Inc. (RLMD) | 15-Dec-15 | Market Purchase | 18,970 | $3.05 | $57,792.10 | 6% 320.35K to 339.32K | 152% |
16-Dec-15 4:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 14-Dec-15 | Market Purchase | 30 | $2.97 | $89.10 | < 1% 320.32K to 320.35K | 159% |
24-Dec-13 3:41 PM View: | Actinium Pharmaceuticals, I... (ATNM) | 08-Aug-13 | Grant | 10,000 | $3.60 | $36,000.00 | (100%) (-10.0K) to 0 |